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ABSTRACT 
Background: There is no evidence to support the use of humidification in low-flow oxygen 
therapy as a usual clinical practice in the management of bronchiolitis. Aims and objectives: To 
investigate the clinical benefits of using humidification in low-flow oxygen therapy. Specific 
objectives were to investigate via an assessment of the number of nasal lavages whether 
humidification can help to decrease the nasal mucus viscosity, to determine whether it can 
relieve feeding difficulties by comparing the weight gain in infants, to ascertain whether it can 
relieve respiratory distress by assessing the heart and respiratory rates and contribute to 
improved clinical outcomes, measured by the length of stay and oxygen requirements. Design: A 
controlled quasi-experimental study. Methods: A total of 97 infants were included, aged ≤ 6 
months, with bronchiolitis, low-flow oxygen therapy and bronchodilators nebulized with 
hypertonic saline 3%. Data from the control group (non-humidified) were gathered from 2010 - 
2012 (49 infants), and data from the group with humidification from 2012 - 2014 (48 infants). 
Linear and Poisson regressions were performed adjusting for relevant characteristics of patients. 
Results: Humidification was shown to be associated with significant reductions in the number of 
nasal lavages in infants with Sant Joan de Déu Bronchiolitis Scores of BROSJOD≤7, in the heart 
rate of infants with mixed bronchodilators treatment, and in the length of stay and oxygen 
requirements of infants with Score BROSJOD≤5. No differences in weight and respiratory rate 
were found. Conclusions: Humidification in low-flow oxygen therapy is an effective nursing 
intervention to improve the clinical outcomes of infants with mild-moderate bronchiolitis. 
Clinical implications: Humidifying the nasal mucosa can help to reduce the need for professional 
procedures, oxygen requirements and hospitalization length. Further research into the economic 
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savings involved is recommended. Key words: Bronchiolitis, Humidification, Low-Flow Oxygen 
Therapy, Infant, Nursing 
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SUMMARY STATEMENT 
'What does this paper contribute to the wider global clinical community?' 
 
 There are no prior recommendations nor any conclusive results related to the clinical benefits 
of humidification in low-flow oxygen therapy in infants. 
 Our findings support the use of humidification in the management of mild to moderate 
bronchiolitis as a usual clinical practice to improve the clinical outcomes and comfort of 
infants. 
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INTRODUCTION 
 Bronchiolitis is the most common lower respiratory infection in infants younger than 
two years of age, and it is mainly caused by the respiratory syncytial virus, RSV. The normal 
epidemic season for bronchiolitis lasts from December to March, and the pathology includes 
acute inflammation, bronchiole edema, and increased mucus production. The signs and 
symptoms begin with rhinitis and cough, which may progress to tachypnea, wheezing, rales, use 
of accessory muscles and/or nasal flaring (American Academy of Pediatrics, 2014). The 
maintenance of hydration and oxygenation, as a supportive treatment, is generally recommended 
to manage acute bronchiolitis, since different trials of other treatments such as corticosteroids or 
antibiotics have not demonstrated conclusive benefits (American Academy of Pediatrics, 2014; 
Krilov, 2011).  
Background 
With regard to oxygenation management, noninvasive ventilation is commonly 
implemented during hospitalization, in the form of either high-flow (HF) oxygen therapy or low-
flow (LF) oxygen therapy. When the HF system is implemented, the humidification of oxygen is 
a usual clinical practice, undertaken in order to prevent some complications of dry oxygen 
delivery, including nasal dryness and discomfort (Cuquemelle et al., 2012). However, despite the 
complications of the dry oxygen conditioning, there is neither a widespread consensus nor any 
standard recommendations about the use of humidified oxygen in LF rates.  
On the one hand, some hospital guidelines always recommend the humidification of 
oxygen in infants, regardless of the flow rates, as the Saskatoon Health Region Nursing Practice 
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Committee policies (2006). On the other hand, Nath, Ponnusany, Willis, Bisset, & Clarke (2010), 
reported a wide variety of clinical practices in the neonatal care with regard to humidification 
measures in LF therapy, thus complicating any effort to define standard policies, as stated above. 
Lastly, Umoren, Odey, & Meremikwu (2011) concluded that there have not been enough well-
designed trials to examine the benefits of humidified oxygen in the treatment of acute 
bronchiolitis in children of up to three years of age. Because of this lack of evidence and 
consensus, both Nath et al. (2010) and Umoren, Odey, & Meremikwu (2011), recommend 
further research to explore the effectiveness of humidified vs. non-humidified oxygen therapy. In 
addition, the humidification may be helpful to prevent the thickening of secretions (Walsh & 
Smallwood, 2017) and relieving the main symptoms of respiratory distress. Finally, no adverse 
effects have been reported, either with steam humidification (Umoren, Odey, & Meremikwu, 
2011), or by using prefilled bubble humidifiers (Yamashita, Nishiyama, Yokoyama, Abe, & 
Manabe, 2005), and only benefits may be expected. 
Thus, given this call for an examination of the benefits of humidified oxygen in low-
flow therapy, the humidification of oxygen in LF was implemented as a general practice in the 
management of all infants with bronchiolitis in our paediatric ward, and we compared its effects 
to non-humidified oxygen therapy. The overall objective was to investigate the clinical benefits 
of using humidification as a usual clinical practice in low-flow oxygen therapy in the 
management of infants with acute bronchiolitis. Our specific hypotheses were that the use of the 
humidification in low-flow oxygen therapy in infants with mild-moderate bronchiolitis would 
reduce their nasal mucus viscosity, thus alleviating the infants’ feeding difficulties and easing 
their respiratory distress, and that it would improve their clinical outcomes. 
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METHODOLOGY 
Design, setting and participants 
A quasi-experimental study with a non-concurrent control group was conducted at our 
general pediatric ward, in a Spanish non-tertiary hospital. A total of 97 infants with mild-
moderate bronchiolitis with low-flow oxygen therapy, defined as ≤ 2 L/min, administered via 
nasal cannula, were enrolled. The control (non-humidified) group data were gathered during the 
annual RSV incidence peak from November to March of the years 2010 to 2012, and consisted 
of observations of 49 infants. The study group (humidified) data were collected in the same 
seasonal period, 2012-2014, with this group consisting of 48 infants. The prevalence of RSV in 
the groups was between 70%-83%, similar to the reference population with bronchiolitis in Spain 
(Flores-González et al., 2017). 
We included all infants younger than six months old, with diagnoses of bronchiolitis 
based on an initial episode of respiratory distress, with LF oxygen therapy, and bronchodilators 
(salbutamol and/or epinephrine), nebulized with hypertonic saline 3%. We excluded infants with 
previous respiratory tract infections and co-infections at admission (pneumonia, bordetella 
pertussis, tract urinary infection), and infants with risk factors for severe disease, such as chronic 
diseases (congenital heart disease, chronic lung disease, immunodeficiency, neuromuscular 
diseases) and premature birth (American Academy of Pediatrics, 2014; Krilov, 2011). Those 
infants who needed different management due to co-infections detected during the bronchiolitis 
treatment, as well as those who ultimately needed to be admitted in the pediatric intensive care 
unit (PICU), were also excluded (Figure 1).  
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--------------------------------------Insert Figure 1 here o near here------------------------------------ 
Study variables 
To evaluate the degree to which humidification can contribute to a decrease in nasal 
mucus viscosity, the number of nasal lavages needed to alleviate the nasal obstruction was 
recorded as an indirect indicator. To assess feeding difficulties, data were gathered on the 
infants’ weight gain, with each infant´s weight in grams recorded at admission and at discharge, 
in each case with the baby naked and weighed on the same digital scale both times. In order to 
evaluate respiratory distress, measurements were taken of the infants’ respiratory rate (RR) 
(counted by professionals during one minute) and of their heart rate (HR) and oxygen saturation 
(SpO2) (measured with pulse-oximetry) at admission and then after 24, 48, and 72 hours, and 
again at discharge. The distress score was also recorded at admission by using the Sant Joan de 
Déu Bronchiolitis Score (BROSJOD) (Balaguer et al., 2017). The bronchodilator therapy was 
recorded, because the use of epinephrine rather than salbutamol may be slightly more effective 
(Modaressi, Asadian, & Faghihinia, 2012). To assess the length of stay (LoS), we defined the 
period of days between the admission in our ward and the validation of the discharge criteria, 
generally when the oral fluid intake was adequate, the SpO2 was >95% without oxygen supply 
for at least twenty-four hours, and the infant exhibited minimal wheezes, rales, and chest 
retractions. To measure the length of oxygen requirement (LOR) we recorded the period of days 
necessary to decrease the work of breathing to the minimum with the supply of oxygen.  
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Potential confounders 
Some potential confounders were controlled for this study; the infants’ age, because 
the most severe bronchiolitis episodes are associated with infants aged less than 12 weeks 
(American Academy of Pediatrics, 2014); the infants’ feeding (categories: breastfeeding, formula 
or mixed), since exclusive breastfeeding may have protective effects on infectious diseases, as 
bronchiolitis (American Academy of Pediatrics, 2014; Duijts, Jaddoe, Hofman, & Moll, 2010); 
the use of antibiotic agents (categories: presence or absence), given that despite the lack of 
evidence of their benefits in treating this viral infection (American Academy of Pediatrics, 
2014), the administering of antibiotics might relieve some symptomatology; the findings in 
radiography and RSV diagnoses (García et al., 2010) (categories: presence or absence), since 
both variables may lead to worsened outcomes. Finally, pre-natal maternal smoking and the 
household smoking exposure were also recorded (categories: yes or no), because household 
tobacco exposure may increase clinical severity in bronchiolitis (Semple, Taylor-Robinson, 
Lane, & Smyth, 2011) 
Procedure  
The choices of management practices for infants with bronchiolitis at our hospital 
always depend on each infant’s clinical status. These interventions range from the maintenance 
of oxygenation through the use of LF when the bronchiolitis episode is mild or moderate and the 
SpO2 <94%, to the maintenance of hydration by encouraging the oral fluid intake in infants 
diagnosed with a mild-moderate episode, and to the prescription of intravenous fluids or tube 
feeding, only in very exceptional and critical situations. They also include the administration of 
bronchodilators by nebulizing salbutamol and/or epinephrine with 3% hypertonic saline and 
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antibiotic therapy. In addition, the nasal lavages are also recommended to alleviate the nasal 
obstruction due to mucus viscosity. This practice consists of the instillation of 2cc to 5cc of 
normal saline into the infant’s nostrils, a process that is much less aggressive than nasal 
suctioning, although it still causes discomfort. Thus, to reduce the discomfort of infants 
associated to nasal lavages, we implemented the humidification in infants with bronchiolitis and 
LF oxygen therapy using the bubble sterile device Respiflo©, Tyco Healthcare (Tyco Healthcare 
Group, 2004a), which has been available in our pediatric ward since November 2012. 
The general procedure during this study was to administer humidification to all infants 
with bronchiolitis who needed LF oxygen therapy, and at the time of admission to register the 
distress score as measured by the Sant Joan de Déu Bronchiolitis Score (BROSJOD) (Balaguer et 
al., 2017), as well as each infant’s vital signs, weight, and potential confounding variables. The 
patients were monitored during their stay, with records taken of their vital signs, and weight at 
discharge. Infants with co-infections and complications were excluded from the study, as 
mentioned above (Figure 1). Because this practice was implemented as a usual prescription, a 
concurrent group without humidification was not possible. 
Data collection 
Data from the from the control, non-humidified group (2010-2012) were collected via 
a review of medical records, and data from the humidified group (2012-2014) were gathered 
using a specific form, designed for the purposes of this study. Demographic data from both 
groups were also recorded. 
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Instruments 
Respiflo© cold bubble device  
This is a closed system with a special adapter, suitable for the administration of 
humidified respiratory gases or/and nebulized therapy. The closed system and the adapters 
reduce the risk of contamination associated with other conventional open systems. This device is 
suitable for the conditioning of dry respiratory gases in short-term low-flow oxygen therapy 
administered with nasal cannulas (Tyco Healthcare Group, 2004; Yamashita et al., 2005)  
Sant Joan de Déu Bronchiolitis Score (BROSJOD) 
The Sant Joan de Déu Bronchiolitis Score (BROSJOD score) was originally 
developed in 1999 (Caritg et al. 1999, cited in Balaguer et al. 2017), and it was recently validated 
as a diagnostic severity tool in infants aged less than two years, mean age 52.5 days, admitted to 
Hospital Sant Joan de Déu with acute bronchiolitis (Emergency Department, ward, or PICU) 
(Balaguer et al. 2017). At admission, the BROSJOD showed good internal consistency 
(Cronbach´s alpha 0.75 [95% CI 0.71- 0.82]), high inter-rater reliability (Concordance 
Correlation Coefficient, CCC 0.96 [95% CI 0.94-0.97]), and good discriminative validity 
(Volume Under Surface, VUS 0.80 [95% CI 0.70-0.90]). This score was specifically developed 
to address the severity of bronchiolitis in children, while other measures as the Wood-Downes 
(WD) scale were adapted from asthma scores and modified for younger children. In addition, the 
BROSJOD score considers RR and HR classified according to the age of infants, and it measures 
data not only on cyanosis but also on oxygen saturation, using pulse-oximetry. Severity score 
values ranged from 1 to 16. Higher scores indicate a more serious condition, with cases classified 
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as mild crises (values 0 to 5), moderate crises (values 6 to 10) or severe crises (values 11 to 16) 
(Balaguer et al. 2017) (Table 1). 
--------------------------------Insert Table 1 here or near here----------------------------------------- 
Ethical aspects 
This study was conducted according to the principles expressed in the Declaration of 
Helsinki of 1975, revised in 1983, and was approved by the Hospital de Terrassa Ethics 
Committee (CEIC, Comité de Ética e Investigación Clínica). The parents’ oral consent was 
obtained, and the data were gathered anonymously. Non-adverse effects were reported by 
professionals and parents.  
Analysis 
Linear and Poisson regressions were performed to investigate the impact of the use of 
humidification in low-flow oxygen therapy in infants with mild-moderate bronchiolitis, adjusting 
for the patients’ relevant characteristics. Furthermore, we tested the interaction of humidification 
with the BROSJOD score to assess whether the impact of humidification on the number of nasal 
lavages, the length of stay (LoS) and the length of oxygen requirement (LOR) was the same at 
different severity levels of bronchiolitis. We also tested the interaction of humidification with the 
type of bronchodilator treatment used in order to assess the impact of humidification on heart 
rate (HR) and respiratory rate (RR). Regression backward model selection was conducted, fitted 
using IBM SPSS Statistics v19.0 package (IBM Corp, 2011). The results of the association 
between treatment (humidification/no humidification) and each response investigated are 
presented as non-linear Poisson regression coefficients (Exp(B)) for count responses, and as 
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linear regression coefficients (B) for quantitative responses, reporting 95% confidence intervals 
(95% CI), and P-values (P) in both cases. 
RESULTS  
Demographic characteristics and descriptive statistics of study variables 
Table 2 shows the infants’ clinical and demographic characteristics. Our groups were 
comparable in age, admission weight, BROSJOD scores, RSV diagnoses, antibiotic therapy, 
radiography findings and family smoking habits. However, the groups showed differences in 
terms of feeding and bronchodilator treatment, so these variables were adjusted in the statistical 
analysis, in regression models. Concerning the group characteristics, 71% of infants in the 
control group (non-humidified) and 83% in the humidified group were diagnosed as RSV 
positive, while most subjects had mild to moderate bronchiolitis scores, were of less than ninety 
days of age and had been exclusively breastfed. Table 3 shows the descriptive statistics and the 
results of the bivariate comparisons for each study variable. 
-----------------------------------Insert Table 2 here or near here-------------------------------------- 
-----------------------------------Insert Table 3 here or near here-------------------------------------- 
Effects of humidification 
In order to analyze the effect of humidification on the number of nasal lavages, a 
Poisson regression model was tested. This model included the interaction of humidification with 
the BROSJOD score adjusting for breastfeeding and age. Table 4 shows the results of the final 
model, where only the interaction of humidification with the BROSJOD score was kept. The 
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humidified group showed a significant reduction in the number of nasal lavages.  As the score 
decreases, the number of nasal lavages is also reduced, with some cases showing a reduction by 
as much as 78.5% (Score BROSJOD= 3) 
-----------------------------------Insert Table 4 here or near here--------------------------------------- 
Concerning feeding difficulties, the infants’ weight gain during the stay was analyzed 
using a linear regression model adjusted for age, but no significant differences were found (B=-
2.456 grams 95% CI: -64.5 – 59.6, p= 0.938). 
To analyze the effect of humidification on respiratory distress, linear regression 
models were tested, with the HR and RR as response variables. This model included the 
interaction of humidification with the BROSJOD score and adjusted for bronchodilators and age. 
Table 5 shows the results of the final model, where only the interaction of humidification with 
bronchodilators remains. Infants with humidification and mixed bronchodilators treatment 
(salbutamol and epinephrine) showed a reduction in HR (B=-11.49 beats 95% CI: -19.68 – -
3.30, p= 0.06). No significant differences in respiratory rates were observed.  
-----------------------------------Insert Table 5 here or near here------------------------------------- 
To analyze the effect of humidification on clinical outcomes, Poisson regression 
models were applied, with LoS and LOR as response variables. These models also included the 
interaction of humidification with the BROSJOD score and were adjusted for admission weight, 
breastfeeding and age. Table 6 shows the final model, where only the interaction of 
humidification with the BROSJOD score was kept. As this score decreases, there is a 
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corresponding reduction in the LoS and LOR, with the values for the latter two variables 
decreasing by as much as 58.2% and 69.5%, respectively (BROSJOD score= 3) 
-----------------------------------Insert Table 6 here or near here------------------------------------- 
DISCUSSION 
Bronchiolitis is an active area of research. Ninety percent of infants are infected with 
RSV in the first two years of life, and the treatment of this virus comes with a huge health care 
cost (American Academy of Pediatrics, 2014). For this reason, numerous reviews are constantly 
being conducted in order to improve the management of these infants (Øymar, Skjerven, & 
Mikalsen, 2014; Schroeder & Mansbach, 2014; Zentz, 2011). In this sense, the use of 
humidification in HF rates is almost an unquestionable clinical practice that helps enhance 
infants’ comfort levels (Cuquemelle et al., 2012) and reduce the risk of complications (Dysart, 
Miller, Wolfson, & Shaffer, 2009). However, as mentioned previously, there are discrepancies in 
the research on the use of humidification in LF, because to date there is no conclusive evidence 
of its benefits (Nath et al., 2010; Umoren et al., 2011). To our knowledge, this is the first study 
reporting clinical benefits of the use of humidification in LF oxygen therapy in mild-moderate 
bronchiolitis.  
Number of nasal lavages 
Humidification seems to be helpful in reducing the number of nasal lavages needed to 
alleviate the nasal obstruction. The data confirm our hypothesis, since the humidification in LF 
may lighten secretions, as Umoren et al. (2011) suggested. In addition, reducing the number of 
nasal lavages may minimize the impact of nursing procedures. This “minimal handling” 
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approach may be especially beneficial in infants aged less than three months, as Øymar et al. 
(2014) suggested. As expected, the effect of the humidification in LF decreased the number of 
nasal lavages in infants with lower BROSJOD scores, since infants scoring higher may need 
other supportive measures, such as heated humidification. 
Feeding difficulties 
The difference in weight gain was not statistically significant. These results, however, 
could have been significantly different if we had measured and analyzed their weight daily to 
examine the fluctuations. In addition, we could have examined how well the infant was feeding 
(i.e., how long it takes to complete a feed, and if the infant is breastfeeding, enquire as to 
whether the mother feels that her breast is being emptied), as Fitzgerald & Kilham (2004) 
recommended as ways to assess the clinical severity of bronchiolitis episodes.  
Respiratory distress 
Humidification decreased the mean HR significantly, and no statistical differences in 
the RR were found. These findings partially confirm our hypothesis, since decreasing the 
thickness of secretions may relieve respiratory distress, as was pointed out by Umoren et al. 
(2011). HR is considered a distress indicator in some instruments assessing bronchiolitis 
severity, including the BROSJOD score and other generally accepted measures like the Wood-
Downes Clinical Scoring System, modified by Ferrés (Flores-González et al., 2016). When these 
instruments are used, lower HR generally contributes to lower scores and thus to decreased 
severity and improvements in infants’ clinical evolution. The RR slightly decreased, but results 
were statistically not significant. This fact may be due to the measuring system used, because 
whereas the HR was measured with a pulse oxymeter, which brings valid and reliable data, RR 
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was measured by professionals, who gathered this data by counting. In this sense, the recording 
of RR may vary from one professional to another, and so the analysis may be altered. So, no 
conclusive results were found concerning RR, but our results regarding the redution of HR were 
statistically significant and may be helpful for future research.  
Length of stay and length of oxygen requirement  
Humidification significantly reduced the LoS and the LOR. These results confirm our 
hypothesis, since lightening secretions and relieving respiratory distress seem to improve infants’ 
clinical outcomes. This effect was associated with lower BROSJOD scores, as well as with 
reduction in the number of nasal lavages required, both these results likely owing to the same 
explanation. Apart from the relationship of humidification with the BROSJOD score, no other 
associations were found, although we initially expected an association between length of stay 
and breastfeeding. The lack of association between these two variables could be explained by the 
fact that most of the infants in our groups were of less than ninety days of age, whereas the 
contribution of exclusive breastfeeding to improve outcomes in respiratory tract infections, 
including reductions in the length of stay, has been described for infants who have been 
exclusively breastfed for at least four months (American Academy of Pediatrics, 2014; Duijts et 
al., 2010) 
Limitations 
Some limitations should be noted and taken into account for further research. Our 
design did not include a concurrent control group without humidification, because this system 
was implemented as a general practice at our ward. While this non-experimental design does not 
ensure the comparability between groups, differences detected between groups regarding 
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potential confounders were controlled for using regression models, as mentioned in the results 
section. We did not have a control group without bronchodilator treatment because our clinicians 
administer bronchodilators as a general rule, as detailed in the procedure section. We recorded 
the clinical distress score at admission to determine the severity of the bronchiolitis episode, but 
we did not register the score evolution during the stay. We did not quantitatively register the oral 
fluid intake of infants during the study, so we could not control for their hydration status as 
would have been desirable. Finally, we could not analyze the interaction of humidification with 
BROSJOD scores over 8, due to the insufficient number of infants in the humidified group.  
Implications for clinical practice and further research 
Humidification in LF may be an effective nursing intervention to improve the 
management of infants with mild-moderate bronchiolitis, reducing the discomfort associated 
with the dry oxygen delivery and nursing handling, relieving respiratory distress and improving 
clinical outcomes. Thus, humidification in low-flow oxygen therapy should be recommended as 
a regular clinical practice, since this viral infection is widespread and highly prevalent. In 
addition, our results may be generalizable to other clinical scenarios in Spain where the 
management of infants with bronchiolitis is very similar, such as in bronchodilators nebulized 
with 3% hypertonic saline and when antibiotics are also prescribed (Flores-González et al., 2016, 
2017). In other countries, clinicians also prescribe antibiotics, bronchodilators and 
corticosteroids, with examples found in Italy (De Brasi et al., 2010) or Finland (Elenius et al., 
2017), despite the fact that administering these treatments has not been shown to have conclusive 
benefits (American Academy of Pediatrics, 2014). Along the same lines, and although nasal 
suctioning is not routinely recommended by the American Academy of Pediatrics guidelines 
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(2014), other protocols and guidelines have highlighted the relevance of suctioning nasal 
secretions before any inhaled therapy application or prior to feeding (Black & Brennan, 2011; 
Cincinnati Children’s Hospital Medical Center, 2006). In these cases, we usually do nasal 
lavages, which are much less aggressive than nasal suctioning. 
Moreover, some others issues concerning the economic costs should also be 
highlighted. Regarding the humidification system implementation, the bubble device in our 
public hospital costs less than one euro per infant/week, whereas a one-day stay costs nearly 300 
euros. Although the costs may vary depending on the device brand used and the clinical scenario, 
the humidification system still remains economical (Villanueva & Bayón, 2013). Additionally, 
other cost savings should be taken into account if the humidification in LF is implemented, 
including the cost-time of the nursing procedures and the medical costs resulting from the 
possible complications of dry oxygen delivery. In this sense, further research is needed, because 
in this study we did undertake an analysis of the cost-effectiveness of humidification in LF. We 
also recommend conducting prospective studies with a control group to clarify the role of 
bronchodilators in association with the humidification, registering the exact dose-frequency of 
epinephrine and salbutamol. Finally, to follow infants’ clinical evolution more accurately, we 
strongly recommend registering distress scores daily, because this measure seems to be a good 
predictor of clinical outcomes, as highlighted by Balaguer et al. (2017) 
CONCLUSION 
The use of humidification in LF oxygen therapy seems to be clinically beneficial. 
Humidifying the nasal and oral mucosa can help to lighten secretions, reduce the number of nasal 
lavages and minimize infants’ discomfort associated with mucosa dryness, nasal obstruction and 
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professional procedures. Humidification also relieves respiratory distress and reduces the LoS 
and the LOR. Our findings support the use of humidification in LF as a regular clinical practice 
in the management of mild-moderate bronchiolitis.  
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Non-humidified group 
Inclusion criteria 
 (n=56) 
  
Humidified group 
Inclusion criteria 
                   (n= 61) 
 
 
  
 
 
Excluded during the study 
 
High Flow           (n=2) 
Pneumonia          (n=3) 
PICU                   (n=2) 
  
Excluded during the study 
 
High Flow         (n= 9) 
Pneumonia        (n= 1) 
Pyelonephritis   (n= 2) 
Bordetella         (n= 1)  
   
 
 
(n= 49) 
  
 (n= 48) 
Figure 1 Flow diagram of selection of study patients 
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Table 1 Bronchiolitis Score of San Joan de Déu, BROSJOD (Balaguer et al., 2017)  
Wheezing/rales 0 No 
  1 Expiratory wheezes /Inspiratory rales 
  2 Expiratory and Inspiratory wheezes/rales 
Indrawing 0 No 
  1 Subcostal + lower intercostal  
  2 Previous + supraclavicular + nasal flaring 
  3 Previous + upper intercostal + tracheal tug 
Air entry  0 Normal  
  1 Regular and symmetric 
  2 Asymmetric  
  3 Very reduced 
Oxygen saturation 
 With oxygen Without oxygen 
0 ≥  95%                      ≥  95%                      
1 91-94% > 94%  with FIO2 ≤40% 
2 ≤90% ≤ 94%  with FIO2 ≤40% 
Respiratory Rate (rpm) 
 0 1 2 3 
< 3 months < 40x’ 40-59x’ 60-70x’ >70x’ 
3-12 months < 30x’ 30-49x’ 50-60x’ >60x’ 
12-24 months < 30x’ 30-39x’ 40-50x’ >50x’ 
Heart Rate (bpm) 
 0 1 2 3 
< 1 year          < 130/x’     130-149/x’     150-170/x’     >170/x’ 
1-2 years < 110/x’     110-120/x’      120-140/x’       >140/x’ 
Note: Fraction of inspired oxygen (FIO2); respirations per minute (rpm); beats per minute (bpm); Overall Score ranked into 
Minor crisis (0-5), Moderate crisis (6-10) and Severe crisis (11-16) 
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Table 2 Demographic and clinical characteristics of infants 
 
Non-humidified 
(n=49) 
Humidified  
(n=48) 
 
 
% (n) % (n) P 
Age   0.768 
<90 days 78 (38) 75 (36)  
>90 days 22 (11)  25 (12) 
Feeding   0.046 
Breastfeeding 59 (29) 73 (35)  
Formula 16 (8) 21 (10) 
Mixed 26 (12) 6 (3) 
Admission weight (grams)   0.641 
 2500-3000 2 (1) 0 (0)  
3001-3500 6 (3) 10 (5) 
3500-4000 14 (7) 17 (8) 
>4001 78 (38) 73 (35) 
Smoking pregnant   0.090 
yes 23 (10) 9 (4)  
no 77 (34) 91 (39) 
Smoking household   0.458 
yes 31 (11) 40 (17)  
no 69 (24) 60 (26) 
Note: Pearson Chi-squared test to compare groups.  Sample (n); p-values (P).  Data are missing on smoking pregnant (n=10, 
10.3%) and smoking household (n=19, 19.6%) 
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Table 3. Descriptive statistics of study variables 
 
  No Humidified  Humidified  
 n M ± Sd n M ± Sd P 
Weight gain (grams)      
 49 0.20 ± 154.9 48 13.5 ± 139.6 .657 
HR (bpm)      
HR 24h 49 147.8 ± 16.7 48 145.1 ± 14.7 .406 
HR 48h 49 145.5 ± 17.3 48 139.2 ± 15.1 .063 
HR 72h 47 140.9 ± 15.6 47 138.7 ± 13.3 .465 
RR (rpm)      
RR 24h 49 44.0 ± 6.6 48 44.1 ± 8.5 .852 
RR 48h 49 44.2 ± 7.5 48 43.0 ± 8.7 .405 
RR 72h 47 41.1 ± 6.5 47 42.5 ± 7.2 .336 
 n Md (IQR) n Md (IQR)  
Nasal lavages (count) 
 49 3 (2 – 9) 48 3 (1 – 5) .467 
Length of Stay and length of oxygen requirement  
LoS 49 5 (4 – 7) 48 5 (4 – 6) .467 
LOR 49 3 (2 – 5) 48 3 (2 – 4) .174 
Note: Sample (n), mean (M), Standard deviation (Sd), median (Md), Interquartile Range (IQR), P-value (P), Heart rate (HR), 
respiratory rate (RR), beats per minute (bpm), respirations per minute (rpm).  
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Table 4 Effects of humidification on number of nasal lavages due to lightening secretions across 
different bronchiolitis severity Score BROSJOD levels  
 
ExpB (95% CI) (ExpB - 1) * 100 P 
Humidification (Yes) 
   
Score 3      (n=4) .341  (.215 – .539) -65.9%  (-78.5%  − -46.1%) < .001 
Score 4    (n=11) .406  (.286 – .577) -59.4%  (-71.4%  − -42.3%) < .001 
Score 5    (n=18) .485  (.375 – .627) -55.1%  (-62.5%  − -37.3%) < .001 
Score 6    (n=24) .579  (.473 – .708) -42.1%  (-52.7%  − -29.2%) < .001 
Score 7    (n=19) .691  (.557 – .855) -30.9%  (-44.3%  − -14.5%) < .001 
Score 8    (n=13) .824  (.619 – 1.09) -17.6%  (-38.1%  − 9.8%)   .186 
Note: Poisson regression coefficients (Exp. (B)), 95% Confidence Intervals (95% CI), p-values (P), sample (n).  
(ExpB - 1) * 100 shows the effect of humidification on the number of nasal lavages expressed in percentage of change. The initial 
model included the interaction of humidification with Score BROSJOD, and age and breastfeeding as potentials confounders, but 
only the interaction with Score BROSJOD was kept in the final model.  
 
Table 5 Effects of humidification on heart rate and respiratory rate in the different bronchodilator 
treatments 
Note: Linear regression coefficients (B), 95% mean confidence intervals (95% CI), and p values (P), HR in beats per minute 
(bpm), RR in respirations per minute(rpm).  The initial model included the interaction of humidification with Score BROSJOD, 
and bronchodilators treatment and age as potential confounders, but only the interaction with bronchodilators was kept in the 
final model.  
 
 
 
 Heart Rate (HR) Respiratory Rate (RR) 
 
B (95% CI) P B (95% CI) P 
Humidification (Yes) 
    
Salbutamol      (n=48) -.649  (-6.30 – 5.00) .822 -7.25 (-14.76 – .26) .058 
Epinephrine    (n=28) .509   (-7.67 – 8.69) .903 -6.50 (-13.67 – .67) .076 
Mixed                (n=21) -11.49  (-19.68 – -3.30) .006 -.028 (-1.98 – 1.92) .978 
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Table 6 Effects of humidification on length of stay and length of oxygen requirement across 
different bronchiolitis severity Score BROSJOD levels 
 
Length of Stay (LoS) 
 
Length of oxygen requirement (LOR) 
 
 
ExpB (95% CI) (ExpB - 1) * 100 P ExpB (95% CI) (ExpB - 1) * 100 P 
Humidification 
      
Score 3     (n=4) .613 (.418 – .899) -38.7% (-58.2% − -10.1%) .012 .502 (.305 – .827) -49.8% (-69.5% − -10.1%) .007 
Score 4    (n=11) .687 (.512 – .920) -31.3% (-48.8% − -8.0%) .012 .610 (.415 – .895) -39.0% (-58.5% − -10.5%) .011 
Score 5    (n=18) .770 (.620 – .955) -23.0% (-38.0%− -4.5%) .017 .740 (.558 – .983) -26.0% (-44.2% − -1.7%) .038 
Score 6    (n=24) .863 (.726 – 1.02) -13.7% (-27.4% − 2.0%) .092 .899 (.721 – 1.121) -10.1% (-27.9% − 12.1%) .345 
Score 7    (n=19) .967 (.803 – 1.16) -3.3% (-19.7% − 16.0%) .723 1.092 (.868 – 1.374) 9.2% (13.2% − 37.4%) .453 
Score 8    (n=13) 1.08 (.845 – 1.39) 8.0% (15.5% − 39.0%) .527 1.326 (.979 – 1.796) 32.6% (-2.4% − 79.6%) .069 
Note: Poisson regression coefficients (Exp(B)), 95% Confidence Intervals (95% CI), and p values (P). LoS and LOR in days. 
(ExpB - 1) * 100 shows the effect of humidification on length of stay and length of oxygen requirement expressed in percentage 
of change. The initial model included the interaction of humidification with Score BROSJOD, and admission weight, 
breastfeeding and age as potential confounders, but only the interaction with Score was kept in the final model.  
 
 
